J Kneer

Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs

Graham Lappin, W. Kuhnz, R. Jochemsen et al. · Clinical Pharmacology & Therapeutics · 2006 · 241 citations

Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys

Andrew J. S. Jones, Damon I. Papac, Edward Chin et al. · Glycobiology · 2007 · 134 citations · Full text

Human Immunoglobulin G, Immunocytochemical Technique, Glycobiology +19

Determination of Midazolam and Its α-Hydroxy Metabolite in Human Plasma and Urine by High-Performance Liquid Chromatography

Huy Riêm Ha, Katharina Rentsch, J Kneer et al. · Therapeutic Drug Monitoring · 1993 · 52 citations

(E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2′-isobutyl-2′-(methanesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a Selective and Orally Active Inhibitor of Tumor Necrosis Factor-α Convertase

Gregory Beck, Gillian A. Bottomley, D. Bradshaw et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 52 citations

Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjects

Robert A. Blouin, J Kneer, K. Stoeckel · Antimicrobial Agents and Chemotherapy · 1989 · 38 citations

Drug Safety, Nutrition, Plasma Half-life +13